Literature DB >> 20303107

Advanced penile verrucous carcinoma treated with intra-aortic infusion chemotherapy.

Maw-Chang Sheen1, Hamm-Ming Sheu, Mei-Yu Jang, Chee-Yin Chai, Yi-Wen Wang, Chih-Fung Wu.   

Abstract

PURPOSE: Traditional treatment for advanced penile verrucous carcinoma is penectomy. This mostly leads to remarkable psychosexual problems and greatly affects quality of life, especially in young patients. To preserve the penis we used intra-aortic infusion chemotherapy for advanced verrucous carcinoma.
MATERIALS AND METHODS: From 1991 to 2009 we treated 6 men with penile verrucous carcinoma with continuous intra-aortic infusion of 50 mg methotrexate every 24 hours (average 550 mg, range 400 to 800). Citrovorum factor (6 mg) was given intramuscularly every 6 hours during methotrexate infusion. After continuous methotrexate infusion no further anticancer drug was given to complete responders. Partial responders subsequently received long-term, intermittent, intra-aortic infusion of 50 mg methotrexate or 2 mg mitomycin C plus 250 mg 5-fluorouracil every 1 to 2 weeks until tumors disappeared and all wounds healed.
RESULTS: After treatment 4 patients achieved a complete response and were disease-free 3 years 9 months to 17 years 10 months (median 11 years 3 months) after therapy. Two patients had a partial response. The patient with a shaft tumor subsequently underwent total penectomy due to unbearable penile pain 4 years after infusion with various drugs without an appreciable response. He has survived 12 years 5 months after initial treatment. The other patient with glans and prepuce tumors had progression with bilateral inguinal metastases despite 1 1/2 years of infusion therapy. Total penectomy was done. Histological examination of the glans mass revealed moderately differentiated squamous cell carcinoma. Patient condition progressed rapidly and he died 11 months after penectomy.
CONCLUSIONS: Intra-aortic infusion chemotherapy is a simple, effective method to treat penile verrucous carcinoma with the uniqueness of preserving the anatomical structure and sexual function in complete responders. For penile verrucous carcinoma, especially in younger patients, intra-aortic infusion chemotherapy may be considered organ sparing treatment before penectomy. 2010 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20303107     DOI: 10.1016/j.juro.2009.12.108

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

1.  Diagnosis and treatment of penile verrucous carcinoma.

Authors:  Fangyin Li; Yipeng Xu; Hua Wang; B O Chen; Zongping Wang; Yang Zhao; Shaoxing Zhu; Guiping Chen
Journal:  Oncol Lett       Date:  2015-01-27       Impact factor: 2.967

2.  A giant verrucous carcinoma of the penis presenting with urinary sepsis and angina.

Authors:  Michael Nomikos; Paschalis Barmpoutis; Eleni Papakonstantinou; Zacharias Chousianitis; Prodromos Ouzounoglou; Paraskevi Efstathiadou; Charilaos Katsifotis
Journal:  Case Rep Med       Date:  2014-11-12

3.  Local Excision for the Treatment of Penile Verrucous Carcinoma.

Authors:  Dong In Jo; Sang Kyu Choi; Soon Heum Kim; Cheol Keun Kim; Hong Chung; Hong Sup Kim
Journal:  Urol Case Rep       Date:  2017-04-10

4.  Optimal treatment for penile verrucous carcinoma: a systematic literature review.

Authors:  Dong In Jo; Song Hyun Han; Soon Heum Kim; Hye Young Kim; Hong Chung; Hong Sup Kim
Journal:  BMC Urol       Date:  2021-01-29       Impact factor: 2.264

5.  Intraarterial chemotherapy as the first-line therapy in penile cancer.

Authors:  P-H Chiang; C-H Chen; Y-C Shen
Journal:  Br J Cancer       Date:  2014-07-24       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.